| Gata2 genotype . | Stage (sp) . | CD31+ . | CD31+ ckit+V− . | CD31+ ckit−V+ . | CD31+ ckit+Vmed . | CD31+ ckit+Vhi . | Number of experiments (embryos) . |
|---|---|---|---|---|---|---|---|
| +/+ | E10 (28–36) | 10,860 ± 1,704 | 1,257 ± 264 | 1,076 ± 153 | 616 ± 223 | 64 ± 16 | n = 5 (25) |
| +/− | E10 (30–36) | 11,664 ± 1,992 | 1,049 ± 258 | 780 ± 179 | 186 ± 60 | 32 ± 6 | n = 3 (19) |
| Gata2 genotype . | Stage (sp) . | CD31+ . | CD31+ ckit+V− . | CD31+ ckit−V+ . | CD31+ ckit+Vmed . | CD31+ ckit+Vhi . | Number of experiments (embryos) . |
|---|---|---|---|---|---|---|---|
| +/+ | E10 (28–36) | 10,860 ± 1,704 | 1,257 ± 264 | 1,076 ± 153 | 616 ± 223 | 64 ± 16 | n = 5 (25) |
| +/− | E10 (30–36) | 11,664 ± 1,992 | 1,049 ± 258 | 780 ± 179 | 186 ± 60 | 32 ± 6 | n = 3 (19) |